2016, Number 1
<< Back Next >>
Dermatología Cosmética, Médica y Quirúrgica 2016; 14 (1)
Cutaneous pseudolymphoma in a pregnant woman in Boyacá, Colombia: A case report
Fonseca RJY, Méndez FYR, Martínez MJS, Mendoza VS, Mendoza RSE, Vega JC
Language: Spanish
References: 11
Page: 28-31
PDF size: 363.99 Kb.
ABSTRACT
Cutaneous pseudolymphoma is a benign entity characterized
by the development of a lesion with abundant polyclonal lymphocytic
infiltrate, it is clinically asymptomatic, with formation
of a violaceous papule or plaque. Clinically and histologically it
could be confused as lymphoma, thus, the study by immunohistochemistry
will be the gold standard for diagnosis. Treatment
consists in surgical resection and the use of sistemic, topical or
infiltrated corticosteroids, its evolution is favorable even to be
resolved without any intervention or just when the cause of the
disease stimulus is removed. We report a case of a pregnant
patient aged 33, diagnosed with cutaneous pseudolymphoma
confirmed by immunohistochemistry markers, the lesion develops
after an insect bite and after biopsy of the lesion it presented
iatrotropism.
REFERENCES
Mahboob, H., Mohammad, S., Manoranjan, V., Aysha, M. y Kavita, G.. “Idiopathic lymphocytoma cutis: a diagnostic dilema”, BMJ Case Reports, 2011, publicado en línea el 28 de marzo de 2011, doi:10.1136/ bcr.12.2010.3662.
Terada, T., “Cutaneous pseudolymphoma: a case report with an inmunohistochemical study”, Int J Clin Exp Pathol, 2013, 6 (5): 966-972.
Pasolini, G., Ghidini, P., Arisi, M., Pedretti, A., Ungari, M. y Pinton, P., “Pseudolymphoma tattoo-induced”, Dermatology Reports, 2011, 3 (3), e47, doi.org/10.4081/dr.2011.e47.
Sá Marchi, M., Domiciano da Silva, J., Fabris, A., Casemiro, K., Fátima de Sá, J. y Kraft, R., “Pseudolinfoma cutâneo: relato de caso”. Rev Soc Bras Clin Med, 2014, 12 (2).
Shtilionova, S., Drumeva, P., Balabanova, M. y Krasnaliev, I., “What is pseudolymphoma and its nature”, Journal of IMAB, 2010, 16 (3): 109.
Baumgartner-Nielsen, J. y Lorentzen, H., “Imiquimod 5%: a successful treatment for pseudolymphoma”, Acta Derm Venereol, 2014, 94: 469.
Bergman, R., “Pseudolymphoma and cutaneous lymphoma: facts and controversies”, Clin Dermatol, 2010, 28: 568-574.
Ko, C.J., “Cutaneous pseudolymphoma: background, pathophysiology, etiolgy”, Medscape Reference, 2014, disponible en: http://emedicine. medscape.com/article/1099188-overview.
Foley, C., Leonard, N. y Wynne, B., “Cutaneous pseudolymphoma: a rare side effect of cyclosporine”, J Am Acad Dermatol, 2015, 72 (3): 85-86.
Camilot, D., Arnez, Z.M., Luzar, B., Pižem, J., Žgavet, B. y Falconieri, G., “Cutaneous pseudolymphoma following tattoo application: report of two new cases of a potential lymphoma mimicker”, Int J Surg Pathol, 2012, 20 (3): 311-315.
Stavrianeas, N.G., Katoulis, A., Bozi, E., Toumbis-Ioannou, E., Kanelleas, A., Makris, M. et. al., “Cutaneous pseudolymphoma following administration of Lornoxicam”, Acta Derm Venereol, 2007, 87 (5): 453-455.
Full text